232 related articles for article (PubMed ID: 1084243)
1. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
Scheinberg MA; Cathcart ES
Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis.
Scheinberg MA; Cathcart ES
Clin Exp Immunol; 1976 May; 24(2):323-7. PubMed ID: 1084244
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
Messner RP; Lindström FD; Williams RC
J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
[TBL] [Abstract][Full Text] [Related]
4. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
Lavalle C; Alcocer J; Gudiño J; Fraga A
Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
[TBL] [Abstract][Full Text] [Related]
5. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.
Bluestein HG; Zvaifler NJ
J Clin Invest; 1976 Feb; 57(2):509-16. PubMed ID: 56343
[TBL] [Abstract][Full Text] [Related]
6. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.
Glinski W; Gershwin ME; Steinberg AD
J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418
[TBL] [Abstract][Full Text] [Related]
7. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A
Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.
Williams RC; Hughes GR; Snaith ML; Parry HF; Diao E; Greaves MF
J Clin Invest; 1980 Feb; 65(2):379-89. PubMed ID: 6153183
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus.
Miyoshi Y; Kilpatrick KA; Kelley RO; Searles RP; Williams RC
J Rheumatol; 1985 Dec; 12(6):1097-104. PubMed ID: 4093915
[TBL] [Abstract][Full Text] [Related]
11. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
Sagawa A; Abdou NI
J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
[TBL] [Abstract][Full Text] [Related]
12. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
Morimoto C
Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
[TBL] [Abstract][Full Text] [Related]
13. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
15. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
Weill BJ; Renoux ML
Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
[TBL] [Abstract][Full Text] [Related]
17. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
18. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.
Utsinger PD
J Rheumatol; 1976 Jun; 3(2):175-85. PubMed ID: 1084929
[TBL] [Abstract][Full Text] [Related]
19. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
